Perrigo | PRGO - Ordinary Share Capital


Perrigo reported $138.1M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 2.94M Mar/2026
Bayer EUR 982.42M 0 Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Dr.Reddys Laboratories INR 832.69M 176K Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
J&J USD 2.41B 1.35M Mar/2026
Merck USD 2.47B 12.72M Dec/2025
Nestle CHF 2.57B 42.99M Dec/2025
Pacira USD 39.31M 1.81M Mar/2026
Perrigo USD 138.1M 500K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Reckitt Benckiser GBP 679.21M 605.21M Jun/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026